Bis-sulfide bioconjugates for glutathione triggered tumor responsive drug release

scientific article published on 01 February 2014

Bis-sulfide bioconjugates for glutathione triggered tumor responsive drug release is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1039/C3CC47003B
P698PubMed publication ID24325005

P50authorTanja WeilQ27981267
Yuzhou WuQ47193759
David Y W NgQ84450643
P2093author name stringTao Wang
Jessica Thomas
Thuy TamTran
P2860cites workRedox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione coupleQ29615232
Synthesis and activity of thioether-containing analogues of the complement inhibitor compstatinQ35109329
Bromomaleimide-linked bioconjugates are cleavable in mammalian cellsQ35873697
Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads.Q36896597
Somatostatin Receptor-Targeted Anti-Cancer TherapyQ37804906
Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene deliveryQ37835914
Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug deliveryQ38082172
In situ maleimide bridging of disulfides and a new approach to protein PEGylationQ39602014
Doxorubicin conjugated to D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS): conjugation chemistry, characterization, in vitro and in vivo evaluationQ39964303
Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug deliveryQ40188447
The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicityQ41566049
Cross-conjugation of DNA, proteins and peptides via a pH switchQ57729196
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectglutathioneQ116907
P304page(s)1116-1118
P577publication date2014-02-01
P1433published inChemical CommunicationsQ426303
P1476titleBis-sulfide bioconjugates for glutathione triggered tumor responsive drug release
P478volume50

Reverse relations

cites work (P2860)
Q38943671A disulfide intercalator toolbox for the site-directed modification of polypeptides.
Q57367017A star-shaped amphiphilic block copolymer with dual responses: synthesis, crystallization, self-assembly, redox and LCST–UCST thermoresponsive transition
Q51004337An oral redox-sensitive self-immolating prodrug strategy.
Q38704033Chemical Protein Modification through Cysteine
Q53642308CuAAC click reactions for the design of multifunctional luminescent ruthenium complexes.
Q37728142Diverse Applications of Nanomedicine
Q51519322Dual pH-responsive 5-aminolevulinic acid pseudopolyrotaxane prodrug micelles for enhanced photodynamic therapy.
Q62117794Functional protein nanostructures: a chemical toolbox
Q62117796Programming Bioactive Architectures with Cyclic Peptide Amphiphiles
Q38555997Protein-polymer therapeutics: a macromolecular perspective.
Q38782458Rational design of multifunctional small-molecule prodrugs for simultaneous suppression of cancer cell growth and metastasis in vitro and in vivo
Q35685706Receptor selective ruthenium-somatostatin photosensitizer for cancer targeted photodynamic applications.
Q38759843Selective chemical labeling of proteins.
Q38990118Site-Selective Disulfide Modification of Proteins: Expanding Diversity beyond the Proteome
Q90550172Site-specific chelator-antibody conjugation for PET and SPECT imaging with radiometals
Q58202898Water-soluble allyl sulfones for dual site-specific labelling of proteins and cyclic peptides
Q35979399pH- and NIR Light-Responsive Polymeric Prodrug Micelles for Hyperthermia-Assisted Site-Specific Chemotherapy to Reverse Drug Resistance in Cancer Treatment.

Search more.